4.8 Article

Association Atudy for 26 Candidate loci in Idiopathic Pulmenary Fibrosis Patients from Four European Populations

Journal

FRONTIERS IN IMMUNOLOGY
Volume 7, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2016.00274

Keywords

MUC5B; MUC2; cytokines; idiopathic pulmonary fibrosis; sequenom MassARRAY; single nucleotide polymorphism; association study; network analysis

Categories

Funding

  1. National Strategic Reference Framework (Greece) [09SYN-12-680]
  2. Hellenic scientific society for rare diseases and orphan drugs
  3. [CZ.1.07/2.3.00/30.0041]
  4. [LO1304]
  5. [IGA_PU_LF_2015_020]
  6. [2016_009]

Ask authors/readers for more resources

Idiopathic pulmonary fibrosis (IPF) affects lung parenchyma with progressing fibrosis. In this study, we aimed to replicate MUC5B rs35705950 variants and determine new plausible candidate variants for IPF among four different European populations. We genotyped 26 IPF candidate loci in 165 IPF patients from four European countries, such as Czech Republic (n = 41), Germany (n = 33), Greece (n = 40), France (n = 51), and performed association study comparing observed variant distribution with that obtained in a genetically similar Czech healthy control population (n = 96) described in our earlier data report. A highly significant association for a promoter variant (rs35705950) of mucin encoding MUC5B gene was observed in all IPF populations, individually and combined [odds ratio (95% confidence interval); p-value as 5.23 (8.943.06); 1.80 X 10-11]. Another non-coding variant, rs7934606 in MUC2 was significant among German patients [2.85 (5.051.60); 4.03 X 10-4] and combined European IPF cases [2.18 (3.161.50); 3.73 X 10-5]. The network analysis for these variants indicated genegene and genephenotype interactions in IPF and lung biology. With replication of MUC5B rs35705950 previously reported in U.S. populations of European descent and indicating other plausible polymorphic variants relevant for IPF, we provide additional reference information for future extended functional and population studies aimed, ideally with inclusion of clinical parameters, at identification of IPF genetic markers.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available